Financial Daily from THE HINDU group of publications
Friday, Jan 27, 2006
News
Features
Stocks
Shipping
Archives
Google

Group Sites

 Corporate - Announcements


Ranbaxy launches diabetes drug

Our Bureau

New Delhi , Jan 26

RANBAXY Laboratories Ltd on Wednesday announced the launch of its branded product Volix (Voglibose), for the treatment of diabetes.

The product, a novel Alpha-Glucosidase inhibitor introduced for the first time in India, will be available in dosages of 0.2 mg and 0.3 mg tablets, said a release.

Voglibose is indicated for improvement of postprandial hyperglycemia in diabetes mellitus only when diet, exercise or oral drugs or insulin preparation in addition to diet and exercise, does not result in adequate glycemic control, it added.

More Stories on : Announcements

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
GHCL to shift Dan River's administrative jobs

ONGC likely to offer gas to Torrent Power's Surat plant
Ranbaxy launches diabetes drug
Indoco Remedies plans US foray with ophthalmic drugs
MICO-Bosch to supply locally made CRDi systems to Suzuki
Gangotri Tex promoters to raise stake thru preferential offer
Suryavanshi Spg defers pref offer
To integrate talent and turn M&As into competitive advantage — Nicholas Piramal on HR revamp exercise
For Kakinada, Barmer refinery projects — ONGC in talks with oil majors for long-term crude supply
Nahar Industrial plans Rs 800-cr capacity expansion
OLHO Technik to set up manufacturing facility in Coimbatore
Bevcon Wayors in pact with Austrian co for `flip-flow' screen tech
Dunlop in talks with global majors for product-specific tie-up — May revive past draft pact with Sumitomo
Apollo Hospitals ties up with Saudi group
Irish beverage major eyes Indian market
RINL wipes out losses
CAs make `misconduct' charge against Lodha

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line